ROP-ET: A Prospective Phase III Trial Investigating the Efficacy and Safety of Ropeginterferon Alfa-2b in Essential Thrombocythemia Patients with Limited Treatment Options

Por: Kiladjian, JJ, Marin, FF, Al-Ali, HK, Alvarez-Larran, A, Beggiato, E, Bieniaszewska, M, Breccia, M, Buxhofer-Ausch, V, Cerna, O, Crisan, AM, Danaila, C, De Stefano, V, Dohner, K, Empson, V, Tybor, JG, Griesshammer, M, Grosicki, S, Guglielmelli, P, Sr, VGG, Heidel, F, Illes, A, James, C, Koschmieder, S, Maria-Theresa, K, Krejcy, K, Lazaroiu, MC, Mayer, J, Nagy, Z, Palandri, F, Pappa, V, Reiter, A, Sacha, T, Schlager, S, Schmidt, SU, Terpos, E, Tomuleasa, C, Torregrosa, JM, Unger, M, Woelfler, A, Xicoy, B and Klade, C

---

Publicada: 5 nov 2024

---

---

Filiaciones:
Kiladjian, JJ:
 Hop St Louis, Ctr Invest Clin, Paris, France

Marin, FF:
 HU Morales Meseguer, Serv Anat Patol, Murcia, Spain

Al-Ali, HK:
 Univ Med Halle, Krukenberg Canc Ctr Halle, Halle, Germany

Alvarez-Larran, A:
 Hosp Clin Barcelona, ICMHO, Hematol Dept, Barcelona, Spain

Beggiato, E:
 AOU Citta Salute & Sci, SC Clin Pharmacol, Turin, Italy

Bieniaszewska, M:
 INFN Torino, Turin, Italy

Breccia, M:
 Univ Clin Ctr, Gdansk, Poland

Buxhofer-Ausch, V:
 Sapienza Univ Rome, Rome, Italy

Cerna, O:
 Charles Univ Prague, Univ Hosp Kralovske Vinohrady, Fac Med 3, Dept Hematol, Prague, Czech Republic

 Charles Univ Prague, Univ Hosp Kralovske Vinohrady, Dept Hematol, Prague, Czech Republic

Crisan, AM:
 Fundeni Clin Inst, Ctr Hematol & Bone Marrow Transplantat, Bucharest, Romania

Danaila, C:
 Reg Inst Oncol, Dept Clin Hematol, Iasi, Romania

De Stefano, V:
 Catholic Univ, Dept Urol, Fdn Policlin Univ A Gemelli IRCCS, Med Sch, Rome, Italy

Dohner, K:
 Univ Hosp Ulm, Dept Radiol, Ulm, Germany

Empson, V:
 AOP Hlth, Vienna, Austria

Tybor, JG:
 Med Univ Lodz, Copernicus Mem Hosp Lodz, Dept Biostat & Translat Med, Dept Hematooncol, Lodz, Poland

Griesshammer, M:
 Univ Bochum, Univ Clin Hematol Oncol Hemostaseol & Palliat Care, Johannes Wesling Med Ctr Minden, Bochum, Germany

Grosicki, S:
 Med Univ Silesia, Fac Hlth Sci Bytom, Dept Hematol & Canc Prevent, Katowice, Poland

Guglielmelli, P:
 Univ Studi Firenze, Florence, Italy

Sr, VGG:
 Univ Alcala, Hosp Univ Ramon & Cajal, Dept Urol, Inst Ramon & Cajal Invest Sanitaria IRYCIS, Madrid, Spain

Heidel, F:
 Hannover Med Sch, Dept Hematol, Hemostasis Oncol & Stem Cell Transplantat, Hannover, Germany

Illes, A:
 Univ Debrecen, Clin Ctr, Debrecen, Hungary

James, C:
 Univ Bordeaux, Biol Cardiovasc Dis, Inserm, UMR1034, Pessac, France

Koschmieder, S:
 Aachen Bonn Cologne Dusseldorf CIO ABCD, Ctr Integrated Oncol, Aachen, Germany

Maria-Theresa, K:
 Med Univ Vienna, Clin Div Hematol & Hemostaseol, Dept Internal Medicine1, Vienna, Austria

Krejcy, K:
 AOP Hlth, Vienna, Austria

Lazaroiu, MC:
 Policlin Diagnost Rapid, Brasov, Romania

Mayer, J:
 Masaryk Univ, Univ Hosp Brno, Brno, Czech Republic

Nagy, Z:
 Semmelwe Egyet, Sportorvostan Tanszek, Budapest, Hungary

Palandri, F:
 Ist Ematol Seragnoli, IRCCS Azienda Ospedaliero Universitaria Bologna, Bologna, Italy

Pappa, V:
 Univ Gen Hosp Attikon, Dept Internal Med & Res Unit 2, Athens, Greece

Reiter, A:
 Univ Med Ctr Mannheim, Dept Hematol & Oncol, Mannheim, Germany

Sacha, T:
 Jagiellonian Univ Hosp Krakow, Krakow, Poland

Schlager, S:
 AOP Hlth, Vienna, Austria

Schmidt, SU:
 Med Univ Innsbruck, Dept Internal Med Hematol & Oncol 5, Innsbruck, Austria

Terpos, E:
 Natl & Kapodistrian Univ Athens, Sch Med, Dept Clin Therapeut, Drosia, Greece

Tomuleasa, C:
 Iuliu Hatieganu Univ Med & Pharm, MedFuture Res Ctr Advance Med, Cluj Napoca, Romania

Torregrosa, JM:
 Univ Poitiers, Chu Poitiers, Poitiers, France

Unger, M:
 AOP Hlth, Vienna, Austria

Woelfler, A:
 Med Univ Graz, Oncol, Graz, Austria

:
 Univ Autonoma Barcelona, Inst Catala Oncol Badalona, Josep Carreras Leukemia Res Inst, Hosp Univ Germans Trias & Pujol, Barcelona, Spain

Klade, C:
 AOP Hlth, Vienna, Austria